Cure My Disease

Don't miss your cure!

 Log in / Sign up

New asthma drug shows Real-World promise for severe cases

NCT ID NCT05677139

Completed Disease control Sponsor: AstraZeneca Source: ClinicalTrials.gov ↗

Summary

This study followed 513 people with severe, hard-to-control asthma for one year after they started taking tezepelumab, a prescription medication. The goal was to see how well the drug worked in everyday life, outside of a controlled clinical trial, by tracking asthma symptoms, breathing tests, and patients' quality of life. Researchers collected data from patients in Europe and Canada to understand the real-world benefits of this treatment.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ASTHMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Research Site

    Innsbruck, Austria

  • Research Site

    Klagenfurt, Austria

  • Research Site

    Vienna, Austria

  • Research Site

    Erpent, Belgium

  • Research Site

    Liège, Belgium

  • Research Site

    Mouscron, Belgium

  • Research Site

    Woluwe-Saint-Lambert, Belgium

  • Research Site

    Yvoir, Belgium

  • Research Site

    Calgary, Alberta, T3B 0M3, Canada

  • Research Site

    Edmonton, Alberta, T6G 1C9, Canada

  • Research Site

    Vancouver, British Colombia, V6E 1Y6, Canada

  • Research Site

    Kingston, Ontario, K7M 7E4, Canada

  • Research Site

    Toronto, Ontario, M5G 1E2, Canada

  • Research Site

    Windsor, Ontario, N8X 5A6, Canada

  • Research Site

    Montreal, Quebec, H1T 2M4, Canada

  • Research Site

    Saskatoon, Saskatchewan, S7N 0W8, Canada

  • Research Site

    Copenhagen, Denmark

  • Research Site

    Hvidovre, Denmark

  • Research Site

    Vejle, Denmark

  • Research Site

    Aschaffenburg, Germany

  • Research Site

    Auerbach, Germany

  • Research Site

    Augsburg, Germany

  • Research Site

    Bamberg, Germany

  • Research Site

    Berlin, Germany

  • Research Site

    Bonn, Germany

  • Research Site

    Cottbus, Germany

  • Research Site

    Düsseldorf, Germany

  • Research Site

    Flensburg, Germany

  • Research Site

    Freiburg im Breisgau, Germany

  • Research Site

    Hamburg, Germany

  • Research Site

    Hanover, Germany

  • Research Site

    Heidelberg, Germany

  • Research Site

    Leipzig, Germany

  • Research Site

    Marburg, Germany

  • Research Site

    München, Germany

  • Research Site

    Schleswig, Germany

  • Research Site

    Stuttgart, Germany

  • Research Site

    Völklingen, Germany

  • Research Site

    Wiesbaden, Germany

  • Research Site

    Jerusalem, Israel

  • Research Site

    Rehovot, Israel

  • Research Site

    Tel Aviv, Israel

  • Research Site

    Ancona, Italy

  • Research Site

    Bergamo, Italy

  • Research Site

    Catanzaro, Italy

  • Research Site

    Florence, Italy

  • Research Site

    Milan, Italy

  • Research Site

    Naples, Italy

  • Research Site

    Palermo, Italy

  • Research Site

    Roma, Italy

  • Research Site

    Siena, Italy

  • Research Site

    Tradate, Italy

  • Research Site

    Stockholm, Sweden

  • Research Site

    Uppsala, Sweden

  • Research Site

    Basel, Switzerland

  • Research Site

    Chur, Switzerland

  • Research Site

    Lugano, Switzerland

  • Research Site

    Sion, Switzerland

Conditions

Explore the condition pages connected to this study.

ASTHMA